Rethinking smoking assessment in head and neck squamous cell carcinoma: are we missing something?

• by Riccardo Gili, Luigi Lorini, Davide Smussi, Armando Di Bello, Paolo Bossi, Carlo Resteghini

• July 1, 2026

Ferroptosis contributes to quercetin-induced anti-cancer activity through blockade of LGR4/NF-κB/GPX4 axis in oral squamous cell carcinoma

• by Xiao-jiao Wang, Peng Zhang, Yue Gao, Yu Shao, Ling Chen

• July 14, 2026

Editorial: The multifaceted role of cholangiocytes in neoplastic and non-neoplastic cholangiopathies: from bench to bedside

• by Alessandro Gambella, Michele Pinon

• July 15, 2026

Inside VIVEbiotech’s Work with Zelluna on TCR-NK Cell Therapy

VIVEbiotech CEO Jon Alberdi lifts the lid on an eight-year collaboration focused on GMP lentiviral vectors for off-the-shelf solid tumor therapies

• July 14, 2026

• 4 min